Equity

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Lupin LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:500257 P/E (TTM) :17.69
ISIN Demat:INE326A01037 Div & Yield %:0.59 EPS (TTM) :115.47
Book Value (RS) :531.5387173 Market Cap (Rs Cr.):93301.24 Face Value (RS) :2
    Change Company 
Particulars Quarter Ended
(Jun 2025)
Quarter Ended
(Jun 2024)
Quarter Ended
(% Var)
Sales 5,605.41 4,084.00 37.25
Other Income 54.14 38.22 41.65
PBIDT 2,783.78 1,237.89 124.88
Interest 18.90 13.55 39.48
PBDT 2,764.88 1,224.34 125.83
Depreciation 176.73 141.42 24.97
PBT 2,588.15 1,082.92 139.00
Tax 451.54 189.19 138.67
Deferred Tax 8.54 4.55 87.69
PAT 2,128.07 889.18 139.33

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)